Crohn's Disease and Colitis Trial, Recruiting NCT06335160 Sponsor: Tanta University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06335160
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older (men and women are both welcome)
  • You have been diagnosed with mild or moderate ulcerative colitis (UC), confirmed by a camera examination of the bowel (endoscopy)
  • You are currently being treated with a medication called mesalamine (also known as 5-aminosalicylic acid)

Who may not be able to join:

  • You have severe ulcerative colitis
  • You have significant problems with your liver or kidney function
  • You have diabetes
  • You have colorectal (bowel) cancer
  • You are using steroid medications, either as a suppository/enema or taken by mouth or injection
  • You are taking medications that suppress the immune system or biological therapies
  • You have an addiction to alcohol or drugs
  • You have a known allergy to any of the medications being studied in this trial
  • You have had surgery to remove all or part of your large bowel (colon)
  • You have heart failure, irregular heartbeat, or any history of heart disease including angina or heart attack
  • You have another inflammatory condition or an active infection
  • You have chronic obstructive pulmonary disease (COPD) or severe obesity (confirm with trial site)
  • You have a liver disease
  • You have low platelet or low white blood cell counts (confirm with trial site)
  • You have any type of seizures or epilepsy
  • You have kidney disease
  • You have a blood clotting disorder
  • You are currently taking a medication called metronidazole (an antibiotic)
  • You have a known allergy to mebendazole, albendazole, or related medications called benzimidazoles
  • You are currently taking antioxidant supplements or medications
  • You are pregnant or breastfeeding
  • You are taking certain other medications including warfarin, low-dose aspirin, clopidogrel, phenytoin, carbamazepine, or valproate (confirm with trial site for the full list)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tanta University
Registry
ClinicalTrials.gov
Start date
20 April 2024
Est. completion
1 April 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

change in disease activity; change in Partial Mayo Scoring Index (PMSI) assessment for Ulcerative Colitis Activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov